EX-99.C 2 d157350dex99c.htm EX-99.C EX-99.C

Exhibit C

Joint Filing Statement

I, the undersigned, hereby express my agreement that the attached Schedule 13D (and any amendments thereto) relating to the beneficial ownership by the undersigned of the equity securities of iTeos Therapeutics, Inc. is filed on behalf of each of the undersigned.

Date: August 7, 2020

 

MPM BIOVENTURES 2014, L.P.
By:   MPM BioVentures 2014 GP LLC,
  its General Partner
By:   MPM BioVentures 2014 LLC,
  Its Managing Member
By:   /s/ Luke Evnin
Name:   Luke Evnin
Title:   Managing Director
MPM BIOVENTURES 2014 (B), L.P.
By:   MPM BioVentures 2014 GP LLC,
  its General Partner
By:   MPM BioVentures 2014 LLC,
  Its Managing Member
By:   /s/ Luke Evnin
Name:   Luke Evnin
Title:   Managing Director
MPM ASSET MANAGEMENT INVESTORS BV 2014 LLC
By:   MPM BioVentures 2014 LLC,
  Its Manager
By:   /s/ Luke Evnin
Name:   Luke Evnin
Title:   Managing Director
MPM BIOVENTURES 2014 GP, LLC
By:   MPM BioVentures 2014 LLC,
  Its Managing Member
By:   /s/ Luke Evnin
Name:   Luke Evnin
Title:   Managing Director


MPM BIOVENTURES 2014 LLC
By:   /s/ Luke Evnin
Name:   Luke Evnin
Title:   Managing Director
MPM BIOVENTURES 2018, L.P.
By:   MPM BioVentures 2018 GP LLC,
  its General Partner
By:   MPM BioVentures 2018 LLC,
  Its Managing Member
By:   /s/ Luke Evnin
Name:   Luke Evnin
Title:   Managing Director
MPM BIOVENTURES 2018 (B), L.P.
By:   MPM BioVentures 2018 GP LLC,
  its General Partner
By:   MPM BioVentures 2018 LLC,
  Its Managing Member
By:   /s/ Luke Evnin
Name:   Luke Evnin
Title:   Managing Director
MPM ASSET MANAGEMENT INVESTORS BV 2018 LLC
By:   MPM BioVentures 2018 LLC,
  Its Manager
By:   /s/ Luke Evnin
Name:   Luke Evnin
Title:   Managing Director
MPM BIOVENTURES 2018 GP, LLC
By:   MPM BioVentures 2018 LLC,
  Its Managing Member
By:   /s/ Luke Evnin
Name:   Luke Evnin
Title:   Managing Director
MPM BIOVENTURES 2018 LLC
By:   /s/ Luke Evnin
Name:   Luke Evnin
Title:   Managing Director

 

Page 2


UBS ONCOLOGY IMPACT FUND , L.P.
By:   Oncology Impact Fund (Cayman) Management L.P.,
  its General Partner
By:   MPM Oncology Impact Management LP,
  Its General Partner
By:   MPM Oncology Impact Management GP LLC
  Its General Partner
By:   /s/ Ansbert Gadicke
Name:   Ansbert Gadicke
Title:   Managing Director
ONCOLOGY IMPACT FUND (CAYMAN) MANAGEMENT L.P.
By:   MPM Oncology Impact Management LP,
  Its General Partner
By:   MPM Oncology Impact Management GP LLC
  Its General Partner
By:   /s/ Ansbert Gadicke
Name:   Ansbert Gadicke
Title:   Managing Director
MPM ONCOLOGY IMPACT MANAGEMENT LP
By:   MPM Oncology Impact Management GP LLC
  Its General Partner
By:   /s/ Ansbert Gadicke
Name:   Ansbert Gadicke
Title:   Managing Director
MPM ONCOLOGY IMPACT MANAGEMENT GP LLC
By:   /s/ Ansbert Gadicke
Name:   Ansbert Gadicke
Title:   Managing Director
By:   /s/ Todd Foley
Name:   Todd Foley
By:   /s/ Luke Evnin
Name:   Luke Evnin
By:   /s/ Ansbert Gadicke
Name:   Ansbert Gadicke
By:   /s/ Edward Hurwitz
Name:   Edward Hurwitz

 

Page 3